NPI: 1487605168 · TAYLOR, MI 48180 · General Acute Care Hospital · NPI assigned 05/15/2006
Authorized official COX, MATTHEW controls 20+ related entities in our dataset. Read more
| Authorized Official | COX, MATTHEW (CHIEF FINANCIAL OFFICER) |
| NPI Enumeration Date | 05/15/2006 |
Other providers sharing the same authorized official: COX, MATTHEW
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 161,893 | $7.18M |
| 2019 | 170,070 | $7.39M |
| 2020 | 143,144 | $6.15M |
| 2021 | 164,549 | $7.32M |
| 2022 | 168,853 | $8.01M |
| 2023 | 176,374 | $8.24M |
| 2024 | 139,528 | $5.99M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 51,540 | 47,657 | $15.70M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 88,490 | 78,233 | $5.39M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 21,440 | 20,855 | $4.05M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 14,023 | 13,640 | $1.93M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 55,986 | 14,039 | $1.80M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 20,630 | 19,505 | $1.72M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 4,010 | 4,000 | $1.46M |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1,856 | 1,845 | $1.00M |
| G0378 | Hospital observation service, per hour | 6,293 | 5,567 | $996K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 6,216 | 6,107 | $937K |
| 71046 | Radiologic examination, chest; 2 views | 17,265 | 16,820 | $903K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 3,942 | 2,177 | $698K |
| 70450 | Computed tomography, head or brain; without contrast material | 7,168 | 7,004 | $583K |
| 20610 | 3,501 | 3,391 | $570K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 34,211 | 9,530 | $493K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4,643 | 4,578 | $430K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 1,810 | 1,805 | $429K |
| 96361 | Intravenous infusion, hydration; each additional hour | 11,781 | 10,287 | $422K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 4,736 | 4,728 | $360K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 576 | 574 | $359K |
| 82947 | 6,782 | 4,593 | $359K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 4,579 | 4,431 | $350K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1,941 | 1,934 | $339K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3,109 | 3,061 | $329K |
| 96375 | Therapeutic injection; each additional sequential IV push | 15,251 | 13,243 | $327K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 5,860 | 5,830 | $299K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 3,066 | 3,023 | $283K |
| 76830 | Ultrasound, transvaginal | 4,614 | 4,582 | $279K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 782 | 779 | $273K |
| 97161 | 5,109 | 5,076 | $270K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 5,178 | 5,170 | $258K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 24,343 | 24,100 | $243K |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 641 | 640 | $239K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 2,881 | 2,828 | $200K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 9,425 | 7,697 | $197K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 11,929 | 11,888 | $189K |
| 71045 | Radiologic examination, chest; single view | 3,723 | 3,616 | $186K |
| 72141 | 1,308 | 1,306 | $182K | |
| 90670 | 3,335 | 3,332 | $174K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 1,882 | 1,881 | $166K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 1,185 | 1,181 | $164K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 2,716 | 2,670 | $164K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1,953 | 1,929 | $160K |
| 90651 | 1,995 | 1,991 | $158K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 15,163 | 12,991 | $156K |
| 97162 | 2,660 | 2,637 | $154K | |
| 62323 | 399 | 394 | $140K | |
| 76770 | 2,335 | 2,322 | $139K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3,388 | 3,329 | $133K |
| 93971 | 2,643 | 2,601 | $131K | |
| 93975 | 1,079 | 1,073 | $126K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 434 | 433 | $123K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 104 | 91 | $118K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 4,574 | 1,404 | $111K |
| 76881 | 1,787 | 1,769 | $109K | |
| 76801 | 1,758 | 1,677 | $108K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 2,841 | 1,823 | $99K |
| 93970 | 835 | 835 | $89K | |
| 76536 | 1,722 | 1,716 | $88K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1,045 | 1,032 | $83K |
| 90686 | 6,902 | 6,868 | $80K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1,379 | 1,341 | $76K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 3,457 | 1,439 | $72K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 138 | 138 | $71K |
| 72110 | 2,588 | 2,576 | $68K | |
| 97014 | 8,619 | 2,554 | $67K | |
| 73564 | 3,222 | 3,130 | $66K | |
| 73130 | 4,850 | 4,452 | $65K | |
| 90677 | 397 | 397 | $63K | |
| 72131 | 1,223 | 1,219 | $63K | |
| 90732 | 620 | 618 | $60K | |
| 90750 | 404 | 403 | $59K | |
| 73610 | 3,847 | 3,595 | $57K | |
| 73030 | 4,473 | 4,307 | $57K | |
| 73630 | 3,952 | 3,795 | $50K | |
| 90716 | 1,508 | 1,507 | $49K | |
| 87428 | 1,636 | 1,617 | $48K | |
| 70486 | 1,259 | 1,255 | $47K | |
| 74022 | 1,886 | 1,864 | $46K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 362 | 362 | $44K |
| 73562 | 4,201 | 4,069 | $43K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 2,163 | 2,131 | $42K |
| 80061 | Lipid panel | 394 | 391 | $41K |
| 73110 | 2,958 | 2,720 | $41K | |
| 73221 | 288 | 288 | $39K | |
| 90734 | 1,572 | 1,570 | $36K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 2,680 | 2,678 | $36K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 243 | 242 | $32K |
| 36415 | Collection of venous blood by venipuncture | 12,085 | 10,209 | $31K |
| 74018 | 1,420 | 1,401 | $31K | |
| 80053 | Comprehensive metabolic panel | 20,545 | 18,669 | $28K |
| 80048 | Basic metabolic panel (calcium, ionized) | 22,530 | 19,916 | $23K |
| 97166 | 514 | 506 | $22K | |
| 29075 | 172 | 153 | $22K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 11,358 | 10,725 | $22K |
| 73502 | 1,396 | 1,375 | $21K | |
| 73080 | 1,672 | 1,549 | $21K | |
| 72050 | 680 | 677 | $21K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 8,043 | 7,804 | $21K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1,711 | 1,692 | $21K |
| 90746 | 295 | 295 | $20K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 692 | 675 | $19K |
| 78226 | 112 | 111 | $19K | |
| 73700 | 316 | 316 | $19K | |
| 73560 | 1,404 | 1,301 | $18K | |
| 90474 | 3,068 | 3,065 | $18K | |
| 72100 | 1,453 | 1,388 | $18K | |
| 97035 | 2,775 | 886 | $16K | |
| 29580 | 242 | 97 | $16K | |
| 99406 | 968 | 946 | $15K | |
| 71271 | 250 | 250 | $14K | |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 2,180 | 2,138 | $14K |
| 97012 | 2,038 | 604 | $13K | |
| 73090 | 1,345 | 1,240 | $13K | |
| 97116 | 831 | 343 | $12K | |
| 91322 | 92 | 92 | $12K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | 15 | 15 | $12K |
| 90671 | 276 | 276 | $12K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2,159 | 2,133 | $11K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2,164 | 2,138 | $11K |
| 73100 | 720 | 638 | $11K | |
| 71250 | 176 | 176 | $11K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1,821 | 1,104 | $11K |
| 86900 | 3,374 | 3,110 | $10K | |
| 97165 | 232 | 229 | $10K | |
| 96367 | 483 | 391 | $10K | |
| 0124A | 294 | 294 | $10K | |
| 99496 | 135 | 135 | $9K | |
| 72040 | 570 | 561 | $8K | |
| 73501 | 706 | 675 | $8K | |
| 10060 | 108 | 104 | $8K | |
| 72082 | 145 | 145 | $7K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3,283 | 3,234 | $7K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1,102 | 1,038 | $7K |
| 73590 | 954 | 907 | $6K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,281 | 2,273 | $6K |
| 93017 | 518 | 515 | $6K | |
| 0054A | 163 | 162 | $6K | |
| 99495 | 94 | 93 | $6K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 218 | 214 | $5K |
| 72070 | 188 | 187 | $5K | |
| 76882 | 108 | 105 | $4K | |
| 81003 | 14,215 | 13,772 | $4K | |
| 87641 | 370 | 370 | $4K | |
| 90480 | 94 | 94 | $4K | |
| 70491 | 27 | 27 | $3K | |
| 80051 | 1,996 | 1,791 | $3K | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 72 | 69 | $3K |
| 87640 | 283 | 283 | $3K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1,376 | 1,352 | $3K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 214 | 210 | $3K |
| 73523 | 52 | 52 | $3K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 41,828 | 36,680 | $3K |
| 86850 | 3,036 | 2,792 | $2K | |
| 76870 | 342 | 338 | $2K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 624 | 615 | $2K |
| 96127 | 160 | 160 | $2K | |
| 85610 | 15,621 | 14,787 | $2K | |
| 20550 | 13 | 13 | $2K | |
| 99382 | 44 | 43 | $2K | |
| 0071A | 55 | 55 | $2K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 106 | 104 | $2K |
| 71101 | 140 | 139 | $2K | |
| 93925 | 14 | 14 | $2K | |
| 81025 | 12,176 | 11,728 | $2K | |
| 73000 | 116 | 105 | $2K | |
| 77080 | 25 | 25 | $2K | |
| 0072A | 42 | 42 | $2K | |
| 81002 | 1,210 | 1,196 | $1K | |
| 25600 | 12 | 12 | $1K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 1,340 | 1,330 | $1K |
| 0001A | 35 | 35 | $1K | |
| 74019 | 122 | 121 | $1K | |
| 0002A | 34 | 34 | $1K | |
| 85027 | 3,263 | 2,643 | $1K | |
| 93880 | 14 | 14 | $1K | |
| 0003A | 28 | 28 | $1K | |
| 76981 | 70 | 70 | $893.22 | |
| 12001 | 212 | 212 | $853.96 | |
| 87631 | 2,114 | 2,085 | $852.61 | |
| 73140 | 46 | 45 | $783.28 | |
| 82607 | 134 | 128 | $750.24 | |
| 86901 | 3,229 | 2,982 | $696.52 | |
| 72072 | 24 | 24 | $651.76 | |
| 97760 | 12 | 12 | $618.80 | |
| 73120 | 62 | 62 | $552.99 | |
| 73070 | 32 | 28 | $550.67 | |
| 72170 | 180 | 180 | $545.15 | |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | 13 | 13 | $507.78 |
| 85730 | 12,939 | 12,309 | $507.35 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3,887 | 3,664 | $503.29 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 4,462 | 4,173 | $500.61 |
| 83735 | 11,897 | 10,307 | $426.26 | |
| 84702 | 3,638 | 3,400 | $411.74 | |
| 87807 | 87 | 87 | $396.32 | |
| 73565 | 14 | 13 | $382.39 | |
| 82728 | 75 | 72 | $360.16 | |
| 83880 | 1,573 | 1,489 | $350.64 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 566 | 509 | $325.14 |
| 82746 | 68 | 63 | $312.84 | |
| 84466 | 59 | 58 | $309.10 | |
| 84484 | 12,817 | 10,166 | $294.59 | |
| 84439 | 82 | 81 | $245.77 | |
| 83970 | 13 | 12 | $241.17 | |
| 73060 | 100 | 95 | $235.81 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1,099 | 1,086 | $228.45 |
| 81001 | 12,975 | 12,449 | $224.32 | |
| 73620 | 163 | 162 | $216.25 | |
| 83690 | 12,104 | 11,363 | $196.54 | |
| 80076 | 2,972 | 2,862 | $191.85 | |
| 83540 | 67 | 65 | $189.52 | |
| 90688 | 44 | 44 | $178.42 | |
| 82565 | 2,605 | 2,242 | $167.35 | |
| 95816 | 12 | 12 | $156.27 | |
| 96376 | 5,723 | 3,171 | $153.76 | |
| 87081 | 1,821 | 1,804 | $142.23 | |
| 29125 | 26 | 26 | $131.30 | |
| G0008 | Administration of influenza virus vaccine | 25 | 25 | $130.66 |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,689 | 1,665 | $125.91 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 1,120 | 796 | $112.70 |
| 82962 | 5,962 | 3,215 | $105.25 | |
| 82550 | 1,302 | 1,231 | $102.19 | |
| 88304 | 579 | 574 | $93.53 | |
| 85379 | 3,067 | 3,000 | $88.05 | |
| 84520 | 2,227 | 2,023 | $87.83 | |
| 87040 | 2,816 | 2,498 | $87.37 | |
| 84100 | 2,305 | 1,983 | $67.69 | |
| 90632 | 141 | 139 | $58.27 | |
| 83605 | 3,519 | 3,162 | $54.16 | |
| 87400 | 1,662 | 1,602 | $53.15 | |
| 80305 | 4,329 | 3,979 | $50.67 | |
| 82044 | 24 | 24 | $47.54 | |
| 73552 | 12 | 12 | $47.36 | |
| 82248 | 2,229 | 2,166 | $42.35 | |
| 87186 | 461 | 449 | $38.19 | |
| 82150 | 1,218 | 1,199 | $37.21 | |
| 88342 | 134 | 132 | $37.05 | |
| 87430 | 1,938 | 1,918 | $34.57 | |
| J3370 | Injection, vancomycin hcl, 500 mg | 1,819 | 1,040 | $30.28 |
| 87077 | 429 | 418 | $30.18 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 561 | 520 | $25.74 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 4,926 | 2,905 | $15.39 |
| 86140 | 52 | 49 | $13.64 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 18,649 | 16,768 | $13.45 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 17,074 | 14,813 | $13.42 |
| 82077 | 257 | 195 | $12.90 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 5,191 | 3,456 | $11.94 |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 41 | 38 | $11.30 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 13,215 | 12,629 | $10.73 |
| 87420 | 575 | 566 | $9.02 | |
| 80179 | 368 | 344 | $8.70 | |
| 80143 | 384 | 353 | $8.70 | |
| 85652 | 39 | 38 | $6.94 | |
| 84295 | 367 | 310 | $6.43 | |
| 90715 | 3,533 | 3,524 | $6.21 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 3,457 | 3,058 | $5.49 |
| J1170 | Injection, hydromorphone, up to 4 mg | 2,656 | 1,842 | $5.36 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 2,656 | 2,412 | $3.51 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 7,411 | 6,821 | $3.39 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 3,391 | 2,826 | $3.18 |
| 84132 | 445 | 377 | $2.91 | |
| 82435 | 365 | 309 | $2.91 | |
| 82374 | 364 | 308 | $2.91 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 4,421 | 3,541 | $2.56 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 4,152 | 3,782 | $2.34 |
| J2060 | Injection, lorazepam, 2 mg | 3,317 | 2,492 | $2.27 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 5,510 | 5,376 | $2.25 |
| J1644 | Injection, heparin sodium, per 1000 units | 4,027 | 1,717 | $2.25 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 10,551 | 8,875 | $1.64 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 368 | 361 | $1.56 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 1,176 | 1,086 | $1.27 |
| J2704 | Injection, propofol, 10 mg | 10,980 | 10,223 | $0.83 |
| 90680 | 2,472 | 2,470 | $0.10 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 1,198 | 1,137 | $0.01 |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 4,262 | 1,218 | $0.00 |
| 90647 | 2,471 | 2,469 | $0.00 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 406 | 365 | $0.00 |
| J3490 | Unclassified drugs | 548 | 536 | $0.00 |
| 90696 | 781 | 781 | $0.00 | |
| 90723 | 2,516 | 2,515 | $0.00 | |
| C9290 | Injection, bupivacaine liposome, 1 mg | 167 | 166 | $0.00 |
| 97010 | 6,391 | 2,179 | $0.00 | |
| 87205 | 182 | 175 | $0.00 | |
| 12002 | 27 | 27 | $0.00 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 138 | 134 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 1,815 | 1,560 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 512 | 338 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 178 | 174 | $0.00 |
| A9573 | Injection, gadopiclenol, 1 ml | 231 | 230 | $0.00 |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | 151 | 147 | $0.00 |
| 87070 | 212 | 205 | $0.00 | |
| 87147 | 59 | 59 | $0.00 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 670 | 623 | $0.00 |
| 90697 | 42 | 42 | $0.00 | |
| 86308 | 150 | 149 | $0.00 | |
| 94760 | 200 | 166 | $0.00 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 151 | 150 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 216 | 215 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 577 | 560 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 80 | 80 | $0.00 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 29 | 29 | $0.00 |
| 93922 | 15 | 15 | $0.00 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 57 | 57 | $0.00 |
| 88311 | 16 | 16 | $0.00 | |
| J7050 | Infusion, normal saline solution, 250 cc | 694 | 612 | $0.00 |
| V2632 | Posterior chamber intraocular lens | 47 | 38 | $0.00 |
| C1889 | Implantable/insertable device, not otherwise classified | 214 | 206 | $0.00 |
| 91307 | 127 | 116 | $0.00 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | 21 | 12 | $0.00 |
| 91305 | 185 | 180 | $0.00 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 23 | 13 | $0.00 |
| J7999 | Compounded drug, not otherwise classified | 12 | 12 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 1,465 | 1,253 | $0.00 |
| 90700 | 511 | 511 | $0.00 | |
| 90707 | 1,517 | 1,516 | $0.00 | |
| 91300 | 160 | 155 | $0.00 | |
| 90633 | 2,277 | 2,276 | $0.00 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 287 | 225 | $0.00 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 343 | 342 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 46 | 39 | $0.00 |
| A9537 | Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | 82 | 81 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 3,490 | 3,437 | $0.00 |
| 94727 | 50 | 50 | $0.00 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 177 | 174 | $0.00 |
| J0694 | Injection, cefoxitin sodium, 1 gm | 37 | 27 | $0.00 |
| C1776 | Joint device (implantable) | 119 | 118 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 102 | 96 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 698 | 441 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 80 | 80 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 1,087 | 928 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 233 | 232 | $0.00 |
| J0735 | Injection, clonidine hydrochloride, 1 mg | 13 | 13 | $0.00 |
| 94729 | 37 | 37 | $0.00 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 74 | 66 | $0.00 |
| 91312 | 294 | 294 | $0.00 | |
| 84145 | 13 | 12 | $0.00 | |
| 77003 | 41 | 40 | $0.00 | |
| 87075 | 14 | 14 | $0.00 | |
| J1956 | Injection, levofloxacin, 250 mg | 14 | 12 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 16 | 16 | $0.00 |
| 87210 | 43 | 43 | $0.00 | |
| 12011 | 12 | 12 | $0.00 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 28 | 26 | $0.00 |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 16 | 16 | $0.00 |
| 82010 | 13 | 12 | $0.00 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 12 | 12 | $0.00 |